Tolerance, kinetics and depth of response for subcutaneous versus intravenous administration of bortezomib combination in Chinese newly diagnosed multiple myeloma patients

The retrospectively investigation compared the efficacy and safety of Bortezomib (Btz) administration via subcutaneous (SC) and intravenous (IV) in 307 newly-diagnosed multiple myeloma (NDMM) patients from a single Chinese center. SC Btz is associated with better tolerance. However, IV administratio...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Lymphoma Myeloma Leuk
Glavni autori: Xu, Yan, Deng, Shuhui, Mao, Xuehan, An, Gang, Li, Zengjun, Wang, Yafei, Fulciniti, Mariateresa, Ho, Matthew, Lin, Jianhong, Sui, Weiwei, Liu, Wei, Zou, Dehui, Yi, Shuhua, Huang, Wenyang, Liu, Hong, Lv, Rui, Li, Jian, Wang, Tingyu, Du, Chenxing, Munshi, Nikhil C, Qiu, Lugui
Format: Artigo
Jezik:Inglês
Izdano: 2018
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5970050/
https://ncbi.nlm.nih.gov/pubmed/29625927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2018.03.006
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items